| Dr Yancy L Van Patten, DO | |
|
One Third Street, Bordentown, NJ 08505-1321 | |
| (609) 298-2005 | |
| (609) 324-8267 |
| Full Name | Dr Yancy L Van Patten |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | One Third Street, Bordentown, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750536033 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 25MB08874600 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Yancy L Van Patten, DO P.o. Box 8500-2946, Phialdelphia, PA 19178-2946 Ph: (609) 815-7810 | Dr Yancy L Van Patten, DO One Third Street, Bordentown, NJ 08505-1321 Ph: (609) 298-2005 |
News Archive
Although important details remain to be negotiated, the legislative leaders and Gov. Deval Patrick, all Democrats, are working toward a plan that would encourage flat "global payments" to networks of providers for keeping patients well, replacing the fee-for-service system that creates incentives for excessive care by paying for each visit and procedure.
At the 64th ASMS Conference, Bruker announces the launch of the new rapifleX™ MALDI PharmaPulse™ (MPP) solution. It is the latest addition to Bruker's portfolio of innovative products designed to assist pharmaceutical, biotech and CRO customers to accelerate drug discovery, and rapifleX MPP can dramatically lower the cost of ultra-high throughput screening (uHTS) with further improved results.
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, today reported encouraging clinical data with its IMGN901 product candidate in the treatment of relapsed and relapsed/refractory multiple myeloma (MM), including prolonged benefit in patients whose disease had progressed on multiple prior treatment regimens.
S1 Pharmaceuticals, Inc. (S1) announced today that it has submitted its Investigational New Drug (IND) application to the U.S. Food and Drug Administration for Phase I-b clinical studies of SIP-104 (Lorexys). Lorexys is the Company's lead drug candidate for the treatment of Hypoactive Sexual Desire Disorder (HSDD) and Female Sexual Dysfunction (FSD).
Children with autism have special difficulty in expressing emotions, usually have no social skills and face major problems when communicating. In order to help children with this problem learn to recognize facial expressions in themselves and in others, a group of researchers at the Tec de Monterrey, in Mexico, created a robot using artificial intelligence.
› Verified 7 days ago
Dr. Joshua Mleczko, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 K Johnson Blvd Ste 101, Bordentown, NJ 08505 Phone: 609-324-8267 | |
Jamie Flynn, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 K Johnson Blvd Ste 101, Bordentown, NJ 08505 Phone: 609-298-2005 Fax: 609-324-8267 | |
Natalie Redziniak, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 K Johnson Blvd Ste 101, Bordentown, NJ 08505 Phone: 609-298-2005 Fax: 609-324-8267 | |
Cynthia Lee Cheng, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 100 K Johnson Blvd Ste 101, Bordentown, NJ 08505 Phone: 609-298-2005 Fax: 609-278-5430 | |
Dr. Timothy Chen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3242 Route 206, Bordentown, NJ 08505 Phone: 609-298-4340 Fax: 609-298-4370 | |
Dr. Hiedi Vizzoni, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Third St, Bordentown, NJ 08505 Phone: 609-298-2005 Fax: 609-324-8267 | |
Janey Hughes, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 K Johnson Blvd Ste 101, Bordentown, NJ 08505 Phone: 609-298-2005 Fax: 609-324-8267 |